findmyKOL

Mattheus Ramsis

Basic profile

University of California San Diego

ORCIDNPI
RegionSan Diego, CA · WestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH funding2026–2026

Mattheus Ramsis is a Cardiology physician affiliated with University of California San Diego. OpenAlex indexes 28 publications with 804 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
28publications

Distinct works indexed by OpenAlex, matched via ORCID.

804citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
9companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2026–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

200 W Arbor Dr
San Diego, CA 921039000

Telephone

800-926-8273

Provider last certified this registry record 31 Jul 2023.

View the NPPES registry record

Industry payments

9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    85.4%
    Statin22.4%
    Rosuvastatin Calcium55%Atorvastatin Calcium38%Pravastatin Sodium8%
    Part D78 patients
    Beta blocker22.4%
    Metoprolol Succinate71%Carvedilol21%Metoprolol Tartrate8%
    Part D100 patients

    + 10 more classes in this area

  • Blood & clotting

    8.2%
    Factor Xa inhibitor6.8%
    Eliquis85%Xarelto15%
    Part D<11 patients
    P2Y12 inhibitor1.4%
    Clopidogrel100%
    Part D11 patients
  • Metabolism & gastrointestinal

    5.5%
    SGLT2 inhibitor4.6%
    Jardiance100%
    Part D19 patients
    Potassium supplement1%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)43.5% facility · 56.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20262026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”